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ABSTRACT
Introduction: Sucking reflex is acknowledged as a comforting mechanism for infants. When used for short periods of time, it is considered a 
healthy habit. Acute otitis media is one of the most frequent infections in pediatric age and has been associated with pacifier misuse.
Objectives: To review available evidence regarding the association between pacifier use in the first years of life and otitis media risk.
Methods: A literature search was conducted on several databases using MeSH terms “otitis” and “pacifiers” for guidelines, systematic 
reviews, randomized controlled trials, and observational studies over the last 20 years.  SORT scale of the American Family Physician was used 
to evaluate evidence levels.
Results: A total of 56 articles were retrieved, of which four guidelines, one systematic review, and one original article were selected. According 
to guidelines, there is no reason to discourage pacifier use, as it can be particularly beneficial in the first six months of life. Afterwards, pacifier 
use should be limited to moments of falling asleep. Its use should also be avoided in infants with chronic or recurrent otitis media. The 
systematic review stablished pacifier use as a risk factor for recurrent acute otitis media (RAOM) which is susceptible to intervention. In the 
observational study, a statistically significant association was found between pacifier use and RAOM risk.
Conclusions: Pacifier use should not be actively discouraged in the first semester of life, as it can have beneficial effects for children (SORT 
A). Afterwards, its use should be discontinued due to increased otitis risk (SORT A).
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RESUMO
Introdução: O reflexo de sucção é reconhecido como um mecanismo de conforto usado pelo lactente. A utilização de chupeta é considerada 
benéfica quando efetuada por curtos períodos de tempo. A otite média aguda é uma das infeções mais frequentes em idade pediátrica e tem 
sido associada ao uso indevido deste objeto.
Objetivos: Rever a evidência científica publicada sobre a associação entre utilização de chupeta nos primeiros anos de vida e risco de otite.
Metodologia: Foi efetuada uma revisão da literatura em várias bases de dados utilizando os termos MeSH “otitis” e “pacifiers”, tendo sido 
pesquisadas orientações, revisões sistemáticas, ensaios clínicos aleatorizados e estudos observacionais publicados nos últimos 20 anos.  Foi 
utilizada a escala SORT da American Family Physician para avaliar os níveis de evidência.
Resultados: No total, foram identificados 56 artigos, dos quais foram selecionadas quatro orientações, uma revisão sistemática e um 
artigo original. De acordo com as orientações, não existe motivo para desencorajar o uso de chupeta, que pode ter efeitos protetores nos 
pequenos lactentes. A sua utilização deve ser descontinuada a partir do segundo semestre de vida, limitando-a aos momentos de adormecer, 
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e deve ser evitada em crianças com antecedentes de otite. A revisão 
sistemática estabeleceu o uso de chupeta como fator de risco para 
otite média aguda recorrente (OMAR) passível de intervenção. O 
estudo observacional encontrou uma associação estatisticamente 
significativa entre o uso de chupeta e risco de OMAR.
Conclusões: O uso de chupeta não deve ser desencorajado no 
primeiro semestre de vida, pois pode ter efeitos benéficos para as 
crianças (SORT A). A partir do segundo semestre, o seu uso deve ser 
descontinuado devido ao risco crescente de otite média aguda (SORT 
A).
Palavras-chave: criança; otite; chupeta; revisão
INTRODUCTION
Nonnutritive sucking is a natural reflex for newborns and babies and 
is recognized as a comforting mechanism. Pacifier has been used as a 
method for fulfilling this innate desire. When used for short periods 
of time, it is considered a healthy routine; however, its prolonged use 
is detrimental.1 
Historically, pacifiers were considered beneficial until the early 
1900s, when an anti-pacifier movement spread concerns about their 
use leading to poor hygiene and indulgent behavior.2 Although nearly 
80% of children in Western countries use pacifiers, the benefit of its 
use is not duly stablished at present.3 
Pacifiers have multiple benefits, including analgesic effects, shorter 
preterm infant hospitalizations, and lower risk of sudden infant death 
syndrome (SIDS).4-6 Pacifier has been recommended for pain relief 
in newborns and infants undergoing minor Emergency Department 
procedures, such as heel sticks, immunization, and venipuncture.4 The 
benefits of its use are also documented in preterm infants regarding 
an improved earlier transition from enteral to bottle feeding.7 The 
American Academy of Pediatrics guidelines suggest offering infants 
pacifiers at the onset of sleep to reduce SIDS risk.6 Although the 
exact mechanism underlying reduction in SIDS rates is not fully 
understood, pacifier use may decrease the likelihood of rolling into 
prone position, increase arousal, and maintain airway patency. It also 
decreases gastroesophageal reflux and resulting sleep apnea.8
Potential complications of pacifier use include negative impact on 
breastfeeding, dental malocclusion, and otitis media and are more 
frequent with prolonged use. Pacifier use may be associated with 
early breast weaning or be a marker of breastfeeding difficulties; 
therefore, it should be avoided until breastfeeding is well established 
(usually by the age of one month).9,10 
Although adverse dental effects may occur after the age of two 
years, they are more significant after the age of four. Therefore, 
pacifier use should be discouraged after this age.11,12
Acute otitis media (AOM) is one of the most frequent infections in 
pediatric age and has been associated with pacifier use. Although 
pacifier use does not increase the risk of respiratory infections, the 
mechanism by which it predisposes to AOM is not understood.13 A 
direct association has been reported between pacifier use frequency 
and AOM risk, with the main theory suggesting a pressure equilibrium 
alteration between the middle ear cavity and nasopharynx, with 
Eustachian tube function impairment. 
The aim of this study was to review available evidence regarding 
an association between pacifier use in the first years of life and otitis 
media risk. 
METHODS
A literature search was conducted in February 2019 on several 
databases using the MeSH terms “otitis” and “pacifiers”. Searched 
databases included the National Guideline Clearinghouse, the 
National Health Service (NHS) Electronic Library, Cochrane Library, 
Database of Abstracts of Reviews of Effectiveness (DARE), Bandolier, 
Canadian Medical Association, the Portuguese Health Authority 
(DGS) database, and PubMed.
Retrieved publication types included guidelines, systematic 
reviews (SR) and meta-analyses (MA), randomized controlled trials 
(RCT), and observational studies published over the last 20 years in 
Portuguese, English, or Spanish language. Articles were selected if 
meeting the following criteria: a) population: children up to five years 
old; b) exposure: pacifier use; c) comparison: no pacifier use; and d) 
outcome: presence of AOM or recurrent otitis. Studies were excluded 
if not meeting inclusion criteria, diverging from the study purpose, 
representing duplicates, or having been included in a MA or SR.
The Strength of Recommendation Taxonomy (SORT) scale of the 
American Family Physician was used to assign evidence levels (EL) 
and assess the strength of recommendations (SR). 
RESULTS
Article selection flow is depicted on Figure 1. Search strategy 
retrieved 56 articles, six of which met pre-defined inclusion criteria 
and were included in the analysis: one original article, one systematic 
review, and four guidelines.
Mohamed Salah et al published a retrospective study in 2013 
analysing risk factors for recurrent AOM (RAOM). RAOM was defined 
as three or more AOM episodes over a six-month period. The study 
included 340 infants below the age of two years diagnosed with 
RAOM, 73 (21.5%) of which were pacifier users. Data was collected 
from parent-fulfilled hospital charts documenting children’s medical 
history. In the study, RAOM was shown to have a statistically 
significant association with pacifier use (p <0.005). Pacifier-using 
children showed a higher RAOM recurrence rate (mean ± standard 
deviation [SD] = 5.8 ± 1.8) compared with non-pacifier-using children 
(mean ± SD = 5.1 ± 1.6). Early recurrence was defined as evidence 
of AOM signs and symptoms one month after initial improvement 
and treatment failure was defined as acute infection persistence or 
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worsening for up to one week following initial treatment. The authors 
found no statistically significant association between pacifier use and 
early recurrence or treatment failure (p >0.05).14 
Figure 1 - Study selection flow during the review process.
SR, systematic review
The systematic review by Lubianca Neto et al analysed evidence 
about modifiable risk factors for AOM and RAOM in children. In this 
study, RAOM was defined as three or more AOM episodes during a 
six-month period or at least four AOM episodes during 12 months. 
The authors searched MEDLINE for studies published from January 
1966 to July 2005 using no language restriction and the descriptors 
“acute otitis media/risk factors” and included three observational 
studies, one MA, and one RCT addressing pacifier use as a risk factor 
for otitis media in infants.15 In one study, pacifier use was significantly 
associated with AOM development from the sixth to the ninth 
months of life (p<0.05) and showed a strong trend towards statistical 
significance in the period from nine to twelve months (p=0.056).16 
According to Niemela et al, pacifier use was significantly associated 
with otitis media (relative risk [RR] 1.48, p=0.01, 95% confidence 
interval [CI] 1.08−2.02).17 In a prospective study, the same authors 
investigated a group of 845 children and concluded that pacifier 
use increased the annual incidence of AOM and was responsible for 
25% of AOM cases.13  In the MA by Uhari et al, pacifier use increased 
AOM relative risk by 24% (RR 1.24; 95% CI 1.06−1.46).18 In the RCT 
conducted by Niemela et al, study intervention consisted in parental 
counselling regarding pacifier use, with parents advised not to use 
pacifier in children after the age of six months. At the end of the study, 
AOM prevalence in the intervention group decreased 29%. Children 
consistently not using pacifier in both intervention and placebo 
groups displayed 33% less AOM episodes. These results suggest that 
restricted pacifier use, limited to falling asleep moments, has the 
potential to reduce AOM risk and that its use should be limited to the 
first ten months of life, when sucking need is more pronounced and 
AOM risk is lower (EL 2).3
The expert panel responsible for the Italian Guidelines for AOM 
management recommends that infants should reduce pacifier use 
to the minimum (SORT A).19 Experts base their recommendation on 
two studies: the previously described SR from Lubianca Neto et al 
and the cohort study from Rovers et al.15,20 The last was performed 
as part of the Utrecht Health Project, which followed 495 children 
aged between zero and four years between 2000 and 2005. Parents 
filled a baseline questionnaire regarding pacifier use and potential 
confounders and AOM was diagnosed by general practitioners. 
Overall, 35% of pacifier-using children and 32% of non-pacifier-using 
children developed at least one AOM episode and 16% and 11% 
developed recurrent AOM (defined as three or more AOM episodes 
during the study period), respectively. The adjusted odds ratio (OR) 
for the correlation between pacifier use and AOM and recurrent AOM 
was 1.3 (95% CI 0.9−1.9) and 1.9 (95% CI 1.1−3.2), respectively.20
The Canadian Pediatric Society guidelines acknowledge pacifier use 
as a risk factor for otitis media, although other factors are implicated 
in the condition’s pathogenesis.21 The risk is proportional to use 
duration and frequency. Therefore, infants and children with chronic 
or recurrent otitis media should have a limited  pacifier use (SORT 
A).21 One study showed that pacifiers were free of the major otitis 
media-causing pathogens and almost 50% of recently used pacifiers 
were uncontaminated.22 In another study, pacifier sucking was 
reported in 40% of 601 children with chronic otitis media requiring 
tympanostomy tubes in Toronto, Ontario.23 
The same guidelines state that pacifier use is a significant risk 
factor for AOM, based on the previously described prospective 
study of children in day care centers and in the MA of otitis media 
risk factors.13,18 One survey to parents of children aged 12 months 
or younger also found an otitis media risk twice as high in pacifier 
users.24 This study was limited by the definition of pacifier use to 
more than five hours per day and by parental reporting reliability. A 
similar study also based on parental reporting found a higher otitis 
media prevalence in pacifier users (OR 1.20).16
The joint recommendations of the American Academy of Family 
Physicians/American Academy of Pediatrics are based on the 
previous studies by Niemela, Uhari, and Rovers.3,18,20 These guidelines 
recommend reducing or stopping pacifier use in the second six 
months of life to reduce otitis media risk (SORT B).7,25 
In 2014, the Portuguese Health Authority (DGS) issued 
recommendations about AOM diagnosis and treatment in pediatric 
age, with pacifier use identified as one of the risk factors for AOM in 
healthy children.26 
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Reference Population Intervention Results EL
Salah M, et al
(2013)
Infants below the age of 2 
years with RAOM
(n=340)
Data collected from 
hospital charts.
Analysis of risk factors 
with potential impact 
on RAOM prognosis, 
including age, 
prematurity, URTIs, 
breastfeeding duration, 
pacifier use, etc.
RAOM showed a 
statistically significant 
association with pacifier 
use (p<0.005). Pacifier-
using infants showed a 
higher recurrence rate 
(mean ± SD = 5.8 ± 1.8) 
compared with non-
pacifier-using infants 
(mean ± SD = 5.1 ± 1.6). 
No statistically significant 
association was found 
between pacifier use 
and early recurrence 
or treatment failure (p 
>0.05).
2 EL, evidence level; 
RAOM, recurrent acute 
otitis media; SD, standard 
deviation; URTI, upper 
respiratory tract infection
EL, evidence level; RAOM, recurrent acute otitis media; SD, standard deviation; URTI, upper respiratory tract infection
OBSERVATIONAL STUDY
Reference Studies included Conclusions EL
Lublianca N, et al
(2006)
- 3 observational studies (n=3158)
- 1 meta-analysis (2 observational studies; 
n=4287)
- 1 randomized controlled trial (n=484)
- Pacifier use increased children’s AOM episode number.
- Pacifier use was significantly associated with AOM from 6 
to 9 months and showed a trend towards significance from 
9 to 12 months (p=0.56).
- AOM risk was 24% higher in pacifier users (RR 1.24, 95% 
CI 1.06−1.46).
- Parental counselling reduced pacifier use and AOM 
incidence by 29%.
2
SYSTEMATIC REVIEW
AOM, acute otitis media; EL, evidence level
Reference Results Sort
Canadian Pediatric Society Infants and children with chronic or recurrent otitis media should have a restricted pacifier use A
American Academy of Family 
Physicians
Pacifier use should be stopped or limited in the second six months of life to reduce otitis media 
risk
B
Italian guidelines Pacifier use should be reduced to a minimum A
Portuguese Health Authority Risk factors for AOM development in healthy children are: (…)pacifier use B
GUIDELINES
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